PDCD1 and neoplasm: Accordingly, high expression of PD-1 in the peripheral blood of tumor patients may inhibit the activation and proliferation of T lymphocytes and weaken the antitumor immune effect of T lymphocytes, forming an immune-tolerant tumor microenvironment.